Imagenomix
New York, US · 3 known investors
Find your way into Imagenomix
Sign up to see every warm intro you have to Imagenomix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imagenomix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
Founders & leadership
AT

Aris TsirigosCo-Founder
MS
Matija SnuderlCo-Founder
DO

Daniel OrringerCo-Founder
TW

Travis WoldChief Executive OfficerHe has held leadership roles in biotech, medical devices, pharmaceuticals, and pathology, with experience spanning product development, commercialization, and sales.
MT

Mikhail TeverovskiyChief Technology Officer
LK
Lizabeth KatsnelsonPrincipal AI Data Scientist
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMay 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Imagenomix do?
- Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
- Who founded Imagenomix?
- Imagenomix was founded by Aris Tsirigos, Matija Snuderl, Daniel Orringer.
- Who are Imagenomix's investors?
- Imagenomix's investors include Metavallon VC, Modi Ventures, Verge HealthTech Fund.
- Where is Imagenomix headquartered?
- Imagenomix is headquartered in New York, US.


